Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

The treatment seems to work best in people with mild or moderate arthritis. It may make good sense if you're trying to delay getting surgery on your joint. Generally, health care providers use ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

The technology was announced at the JP Morgan Healthcare Conference in San Francisco. In this project, the stakeholders aim to use a human reference genome to combine with patient data in order to try ...

Background: The anti-interleukin (IL) 6 receptor antibody tocilizumab inhibits signalling of IL6, a key cytokine in rheumatoid arthritis (RA) pathogenesis. Objective: To evaluate through the AMBITION ...

12 University of California, San Francisco/Synarc, San Francisco, California, USA 13 Synarc, Inc, San Francisco, California, USA Objectives: To assess the efficacy and safety of abatacept in ...

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

Although Arthritis Today magazine is no longer published, sign up below to receive healthy living tips and resources in our Arthritis Today and other e-newsletters, delivered right to your inbox.

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

This year, older workers will have ways to save more for retirement, spend less on medicine and see other ways to improve ...